Jeffrey M. Trent

53.5k total citations · 10 hit papers
384 papers, 31.5k citations indexed

About

Jeffrey M. Trent is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Jeffrey M. Trent has authored 384 papers receiving a total of 31.5k indexed citations (citations by other indexed papers that have themselves been cited), including 229 papers in Molecular Biology, 105 papers in Genetics and 86 papers in Cancer Research. Recurrent topics in Jeffrey M. Trent's work include Cancer Genomics and Diagnostics (60 papers), Molecular Biology Techniques and Applications (49 papers) and Genomic variations and chromosomal abnormalities (43 papers). Jeffrey M. Trent is often cited by papers focused on Cancer Genomics and Diagnostics (60 papers), Molecular Biology Techniques and Applications (49 papers) and Genomic variations and chromosomal abnormalities (43 papers). Jeffrey M. Trent collaborates with scholars based in United States, Canada and United Kingdom. Jeffrey M. Trent's co-authors include Paul S. Meltzer, Michael Bittner, Xin‐Yuan Guan, Patrick O. Brown, Yan Su, Mary J.C. Hendrix, Paul Meltzer, Elisabeth A. Seftor, Albert J. Fornace and Sally A. Amundson and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Jeffrey M. Trent

370 papers receiving 30.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Vascular Channel Formation by Human Melanoma Cells in Vivo and in Vitro: Vasculogenic Mimicry

1999 1.6k citations Jeffrey M. Trent, Mary J.C. Hendrix et al. profile →
The Transcriptional Program in the Response of Human Fibroblasts to Serum

1999 1.6k citations Jeffrey M. Trent et al. profile →
Use of a cDNA microarray to analyse gene expression patterns in human cancer

1996 1.5k citations Michael Bittner, Paul S. Meltzer et al. profile →
AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian Cancer

1997 1.4k citations David O. Azorsa, Olli Kallioniemi et al. profile →
Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour

1983 1.2k citations Jeffrey M. Trent et al. profile →
KiSS-1, a Novel Human Malignant Melanoma Metastasis-Suppressor Gene

1996 831 citations Jeffrey M. Trent, Bernard E. Weissman et al. profile →
Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma

2002 756 citations Ashani T. Weeraratna, Yuan Jiang et al. profile →
Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines

1985 701 citations Jeffrey M. Trent et al. profile →
Identification of an Amplified, Highly Expressed Gene in a Human Glioma

1987 541 citations Jeffrey M. Trent et al. profile →
Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc

1984 252 citations Jeffrey M. Trent et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeffrey M. Trent United States	89	20.5k	7.3k	6.1k	5.9k	3.5k	384	31.5k
Paul S. Meltzer United States	93	22.7k 1.1×	9.2k 1.3×	5.3k 0.9×	7.2k 1.2×	5.6k 1.6×	384	36.0k
Yusuke Nakamura Japan	82	15.2k 0.7×	8.0k 1.1×	3.6k 0.6×	5.4k 0.9×	2.4k 0.7×	377	25.6k
Peter Lichter Germany	100	19.4k 0.9×	6.7k 0.9×	7.2k 1.2×	6.0k 1.0×	2.7k 0.8×	490	36.6k
David J. Kwiatkowski United States	101	15.9k 0.8×	7.3k 1.0×	4.1k 0.7×	3.9k 0.7×	7.0k 2.0×	395	33.3k
Thomas Ried United States	84	17.7k 0.9×	7.3k 1.0×	6.2k 1.0×	6.2k 1.1×	1.9k 0.5×	378	27.8k
Scott L. Pomeroy United States	49	27.9k 1.4×	6.7k 0.9×	3.4k 0.6×	9.8k 1.7×	6.3k 1.8×	117	44.5k
Michael Wigler United States	103	35.3k 1.7×	7.2k 1.0×	10.6k 1.7×	6.2k 1.1×	2.0k 0.6×	222	47.0k
Daniel Birnbaum France	93	17.3k 0.8×	12.8k 1.7×	3.5k 0.6×	7.5k 1.3×	2.8k 0.8×	558	31.8k
Charles Lee United States	75	14.6k 0.7×	5.9k 0.8×	8.8k 1.4×	4.3k 0.7×	5.6k 1.6×	318	28.0k
Jerry W. Shay United States	118	35.3k 1.7×	8.9k 1.2×	5.2k 0.9×	4.9k 0.8×	3.5k 1.0×	522	58.0k

Countries citing papers authored by Jeffrey M. Trent

Since Specialization

Citations

This map shows the geographic impact of Jeffrey M. Trent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey M. Trent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey M. Trent more than expected).

Fields of papers citing papers by Jeffrey M. Trent

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey M. Trent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey M. Trent. The network helps show where Jeffrey M. Trent may publish in the future.

Co-authorship network of co-authors of Jeffrey M. Trent

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey M. Trent. A scholar is included among the top collaborators of Jeffrey M. Trent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey M. Trent. Jeffrey M. Trent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ebrahimi, Hedyeh, Luís Meza, Nazlı Dizman, et al.. (2025). Cabozantinib (cabo) and nivolumab (nivo) with or without CBM588 in patients with metastatic renal cell carcinoma: Updated clinical outcomes of a phase I study.. Journal of Clinical Oncology. 43(5_suppl). 543–543. 1 indexed citations

Chehrazi‐Raffle, Alex, Ramya Muddasani, Nazlı Dizman, et al.. (2023). Ultrasensitive Circulating Tumor DNA Pilot Study Distinguishes Complete Response and Partial Response With Immunotherapy in Patients With Metastatic Renal Cell Carcinoma. JCO Precision Oncology. 7(7). e2200543–e2200543. 10 indexed citations

Lorch, Gwendolen, Karthigayini Sivaprakasam, Victoria Zismann, et al.. (2019). Identification of Recurrent Activating HER2 Mutations in Primary Canine Pulmonary Adenocarcinoma. Clinical Cancer Research. 25(19). 5866–5877. 28 indexed citations

Wang, Yemin, Shane Colborne, Nancy Dos Santos, et al.. (2018). Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type. Molecular Cancer Therapeutics. 17(12). 2767–2779. 52 indexed citations

Zhang, Tongwu, Mai Xu, Matthew Makowski, et al.. (2017). SDHD Promoter Mutations Ablate GABP Transcription Factor Binding in Melanoma. Cancer Research. 77(7). 1649–1661. 10 indexed citations

Ruiz, Christian, Elizabeth Lenkiewicz, Lisa Evers, et al.. (2011). Advancing a clinically relevant perspective of the clonal nature of cancer. Proceedings of the National Academy of Sciences. 108(29). 12054–12059. 90 indexed citations

Henderson, Meredith C., Shilpi Arora, Ashish Choudhary, et al.. (2011). High-throughput RNAi Screening Identifies a Role for TNK1 in Growth and Survival of Pancreatic Cancer Cells. Molecular Cancer Research. 9(6). 724–732. 26 indexed citations

Sekulić, Aleksandar, Su Y. Kim, Galen Hostetter, et al.. (2010). Loss of Inositol Polyphosphate 5-Phosphatase Is an Early Event in Development of Cutaneous Squamous Cell Carcinoma. Cancer Prevention Research. 3(10). 1277–1283. 30 indexed citations

Gartside, Michael G., Huaibin Chen, Omar A. Ibrahimi, et al.. (2009). Loss-of-Function Fibroblast Growth Factor Receptor-2 Mutations in Melanoma. Molecular Cancer Research. 7(1). 41–54. 102 indexed citations

10.

Amundson, Sally A., T. Khanh, Lisa C. Vinikoor, et al.. (2008). Integrating Global Gene Expression and Radiation Survival Parameters across the 60 Cell Lines of the National Cancer Institute Anticancer Drug Screen. Cancer Research. 68(2). 415–424. 207 indexed citations

11.

Basu, Gargi D., David O. Azorsa, Jeffrey Kiefer, et al.. (2008). Functional evidence implicating S100P in prostate cancer progression. International Journal of Cancer. 123(2). 330–339. 62 indexed citations

12.

Dissanayake, Samudra K., Michael S. Wade, Carrie E. Johnson, et al.. (2007). The Wnt5A/Protein Kinase C Pathway Mediates Motility in Melanoma Cells via the Inhibition of Metastasis Suppressors and Initiation of an Epithelial to Mesenchymal Transition. Journal of Biological Chemistry. 282(23). 17259–17271. 294 indexed citations

13.

Borad, Mitesh J., Robert Penny, Michael Bittner, et al.. (2006). Molecular profiling using immunohistochemistry (IHC) and DNA microarray (DMA) as a tool to determine potential therapeutic targets in patients who have progressed on multiple prior therapies. Clinical Cancer Research. 12. 4 indexed citations

14.

Qin, Jian‐Zhong, Lawrence Stennett, Barbara Bodner, et al.. (2005). Proteasome Inhibitors Trigger NOXA-Mediated Apoptosis in Melanoma and Myeloma Cells. Cancer Research. 65(14). 6282–6293. 263 indexed citations

15.

Zheng, Siqun L., Josyf C. Mychaleckyj, Gregory A. Hawkins, et al.. (2003). Evaluation of DLC1 as a prostate cancer susceptibility gene: mutation screen and association study. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 528(1-2). 45–53. 16 indexed citations

16.

Bomprezzi, Roberto, Markus Ringnér, Seungchan Kim, et al.. (2003). Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease. Human Molecular Genetics. 12(17). 2191–2199. 167 indexed citations

17.

Xu, Jianfeng, Carl D. Langefeld, S. Lilly Zheng, et al.. (2003). Interaction effect of PTEN and CDKN1B chromosomal regions on prostate cancer linkage. Human Genetics. -1(1). 1–1. 17 indexed citations

18.

Luo, Jun, Thomas A. Dunn, Charles M. Ewing, et al.. (2002). Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis. The Prostate. 51(3). 189–200. 109 indexed citations

19.

Trent, Jeffrey M. & Roger Buick. (1981). Cytogenetic analysis of clonogenic human ovarian carcinoma cells exposed to cytostatic agents. Proceedings of the American Association for Cancer Research. 22. 1 indexed citations

20.

Stanisic, Thomas H., Roger Buick, & Jeffrey M. Trent. (1980). In vitro clonal assay for bladder cancer: The biologic potential of urothelium and determination of in vitro sensitivity to cytotoxic agents. 31. 585–587. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact